Browse > Article
http://dx.doi.org/10.15324/kjcls.2021.53.2.151

Quantitative Analysis of Electrophysiological Characteristics of CIDP and CMT Type 1: Sensory Nerve Research  

Kang, Ji-Hyuk (Department of Biomedical Laboratory Science, College of Health and Medical Science, Daejeon University)
Publication Information
Korean Journal of Clinical Laboratory Science / v.53, no.2, 2021 , pp. 151-157 More about this Journal
Abstract
Charcot-Marie-Tooth disease (CMT) is a slowly progressive hereditary degenerative disease and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an acquired immune-mediated disorder characterized by weakness and sensory deficits. The purpose of this study was to analyze and compare the electrophysiological characteristics observed in sensory nerve conduction studies (SNCS) of both diseases. A retrospective study of 65 patients with a diagnosis of CIDP (N=35) and CMT type I (N=30) was performed. This study analyzed No potentials ratio, distal compound nerve action potential (dCNAP) of various nerve types, and a correlation coefficient analysis of the sensory nerve conduction velocity (SNCV). As a result, I found that CMT 1 was more severe systemic demyelinating and axonal polyneuropathy better than CIDP (P<0.05). In a quantitative analysis of dCNAP and SNCV, especially sural nerve was the most severe nerve injury observed in both diseases. In correlation and scatter plot analysis, CMT 1 showed relatively high correlations compared to CIDP based on the correlation coefficient analysis (Fisher's Z test) of SNCV. The results of this study suggested that CMT 1 showed the slowness in SNCV, one of the characteristics of demyelinating polyneuropathy, and this slowing had a uniform pattern. In conclusion, electrophysiological characteristic of SNCS may be useful in the diagnosis and research between patients with CMT 1 and CIDP.
Keywords
CIDP; CMT 1; dCNAP; SNCV;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Berciano J, Garcia A, Gallardo E, Peeters K, Pelayo-Negro AL, Alvarez-Paradelo S, et al. Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review. J Neurol. 2017;264:1655-1677. https://doi.org/10.1007/s00415-017-8474-3   DOI
2 Latour P, Gonnaud PM, Ollagnon E, Chan V, Perelman S, Stojkovic T, et al. Simple mutation analysis in dominant demyelinating Charcot-Marie-Tooth disease three novel mutations. J Peripher Nerv Syst. 2006;11:148-155. https://doi.org/10.1111/j.1085-9489.2006.00080.x   DOI
3 Jeng LJ, Balice-Gordon RJ, Messing A, Fischbeck KH, Scherer SS. The effects of a dominant connexin32 mutant in myelinating Schwann cells. Mol Cell Neurosci. 2006;32:283-298. https://doi.org/10.1016/j.mcn.2006.05.001   DOI
4 Kim SB, Park KD, Choi BO. Diagnosis and treatment in Charcot-Marie-Tooth disease. Ann Clin Neurophysiol. 2005;7: 65-74.
5 Pareyson D, Scaioli V. Clinical and electrophysiological aspects of Charcot-Marie-Tooth disease. Neuromolecular Med. 2006;8: 3-22. https://doi.org/10.1385/nmm:8:1-2:3   DOI
6 Stanton M, Pannoni V, Lewis RA, Logigian EL, Naguib D, Shy ME, et al. Dispersion of compound muscle action potential in hereditary neuropathies and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2006;34:417-422. https://doi.org/10.1002/mus.20600   DOI
7 Lehmann HC, Burke D, Kuwabara S. Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment. J Neurol Neurosurg Psychiatry. 2019;90:981-987. https://doi.org/10.1136/jnnp-2019-320314   DOI
8 Bunschoten C, Jacobs BC, Van den Bergh PYK, Cornblath DR, van Doorn PA. Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy. Lancet Neurol. 2019;18:784-794. https://doi.org/10.1016/S1474-4422(19)30144-9   DOI
9 Escorcio-Bezerra ML, Pinto WBVR, Bichuetti DB, Souza PVS, Nunes RM, Silva LHL, et al. Immune-mediated inflammatory polyneuropathy overlapping Charcot-Marie-Tooth 1B. J Clin Neurosci. 2020;75:228-231. https://doi.org/10.1016/j.jocn.2020.03.014   DOI
10 Kang JH, Lee YS. Sensory nerve conduction studies in the diagnosis of diabetic sensorimotor polyneuropathy: electrophysiological features. J Phys Ther Sci. 2012;24:139-142.   DOI
11 Staudt M, Diederich JM, Meisel C, Meisel A, Klehmet J. Differences in peripheral myelin antigen-specific T cell responses and T memory subsets in atypical versus typical CIDP. BMC Neurol. 2017;17:81. https://doi.org/10.1186/s12883-017-0860-z   DOI
12 Garg N, Howells J, Yiannikas C, Vucic S, Krishnan AV, Spies J, et al. Motor unit remodelling in multifocal motor neuropathy: The importance of axonal loss. Clin Neurophysiol. 2017;128:2022-2028. https://doi.org/10.1016/j.clinph.2017.07.414   DOI
13 Stino AM, Naddaf E, Dyck PJ, Dyck PJB. Chronic inflammatory demyelinating polyradiculoneuropathy-Diagnostic pitfalls and treatment approach. Muscle Nerve. 2021;63:157-169. https://doi.org/10.1002/mus.27046   DOI
14 Kuwabara S, Misawa S. Chronic inflammatory demyelinating polyneuropathy. Adv Exp Med Biol. 2019;1190:333-343. https://doi.org/10.1007/978-981-32-9636-7_21   DOI
15 Oh SJ. Clinical electromyography. Nerve conduction studies, third edition. Philadelphia: Lippincott Williams & Wilkins, 2003;86-135.
16 Mary MR. Axonal charcot-Marie-Tooth disease. Neurology. 2005; 65:186-187. https://doi.org/10.1212/01.wnl.0000173904.97549.94   DOI
17 Harding AE, Thomas PK. Genetic aspects of hereditary motor and sensory neuropathy (types I and II). J Med Genet. 1980; 17:329-336. https://doi.org/10.1136/jmg.17.5.329   DOI
18 Manganelli F, Pisciotta C, Reilly MM, Tozza S, Schenone A, et al. Nerve conduction velocity in CMT1A: what else can we tell?. Eur J Neurol. 2016;23:1566-1571.   DOI
19 Kang JH, Kim HJ, Lee ER. Electrophysiological evaluation of chronic inflammatory demyelinating polyneuropathy and charcot-marie-tooth type 1: dispersion and correlation analysis. J Phys Ther Sci. 2013;25:1265-1268. https://doi.org/10.1589/jpts.25.1265   DOI